SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-040184
Filing Date
2022-02-14
Accepted
2022-02-14 10:16:02
Documents
2
Group Members
CHARLES I. CLOUGH, JR.CLOUGH CAPITAL PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d267372dsc13ga.htm SC 13G/A 73194
2 EX-99.1 d267372dex991.htm EX-99.1 6296
  Complete submission text file 0001193125-22-040184.txt   81080
Mailing Address 53 STATE STREET 27TH FLOOR BOSTON MA 02109
Business Address 53 STATE STREET 27TH FLOOR BOSTON MA 02109 6172043400
CLOUGH CAPITAL PARTNERS L P (Filed by) CIK: 0001276144 (see all company filings)

IRS No.: 043486480 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Subject) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91617 | Film No.: 22626658
SIC: 2836 Biological Products, (No Diagnostic Substances)